Other

Payments to Acquire Marketable Securities

Year-over-year, this metric declined by 100.0%, from $630.52M to $0.00. Over 4 years (FY 2021 to FY 2025), Payments to Acquire Marketable Securities shows an upward trend with a 154.0% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2025
Last reportedQ1 2026

How to read this metric

High outflows indicate the company is deploying excess cash into investments rather than operations or debt reduction.

Detailed definition

This metric tracks cash outflows used to purchase short-term or long-term investment securities, such as stocks, bonds,...

Peer comparison

Standard investing activity item for companies with significant treasury management functions.

Metric ID: other_payments_to_acquire_marketable_securities

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$50.29M$99.71M$0.00$0.00$0.00$0.00$292.69M-$1.00K$296.04M$0.00$0.00$999.78M$577.47M$630.52M$276.68M$1.18B$0.00$0.00
QoQ Change+98.3%-100.0%-100.0%>999%-100.0%-42.2%+9.2%-56.1%+328.2%-100.0%
YoY Change-100.0%-100.0%-100.0%>999%+95.1%+18.5%-100.0%-100.0%
Range-$1.00K$1.18B
Avg YoY Growth>999%
Median YoY Growth-100.0%
Current Streak2 quarters decline

Frequently Asked Questions

What is Insmed's payments to acquire marketable securities?
Insmed (INSM) reported payments to acquire marketable securities of $0.00 in Q1 2026.
How has Insmed's payments to acquire marketable securities changed year-over-year?
Insmed's payments to acquire marketable securities decreased by 100.0% year-over-year, from $630.52M to $0.00.
What is the long-term trend for Insmed's payments to acquire marketable securities?
Over 4 years (2021 to 2025), Insmed's payments to acquire marketable securities has grown at a 154.0% compound annual growth rate (CAGR), from $50.29M to $2.09B.
What does payments to acquire marketable securities mean?
Cash spent on buying investment securities.